• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/155 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Patent holdings for IPC class C07D 295/155

Total number of patents in this class: 388

10-year publication summary

26
29
31
25
16
29
15
19
18
9
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4742
10
The Regents of the University of California
20745
10
Duke University
3183
7
Amyris, Inc.
372
7
Boehringer Ingelheim International GmbH
4493
6
The Cooper Health System
46
6
Nerviano Medical Sciences S.r.l.
237
6
Abbott Laboratories
2254
5
President and Fellows of Harvard College
6094
5
Aurimmed Pharma, Inc.
7
5
CHDI Foundation, Inc.
107
5
SRI International
992
5
Tetraphase Pharmaceuticals, Inc.
52
5
VALO Health, Inc.
193
5
Janssen Pharmaceutica N.V.
3168
4
Centre National de La Recherche Scientifique
11023
4
The General Hospital Corporation
4870
4
Abbvie Inc.
1836
4
Arena Pharmaceuticals, Inc.
344
4
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
75
4
Other owners 277